Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/2/18 → 10/2/24 |
Funding
- Parexel ((OE) Prot #0610-02 // (OE) Prot #0610-02)
- Constellation Pharmaceuticals, Inc. ((OE) Prot #0610-02 // (OE) Prot #0610-02)
Prot #0610-02: A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients wi
- Stein, Brady Lee (PD/PI)
Project: Research project